Real-World Evidence (RWE) Centre of Expertise
The RWE Centre of Expertise, part of Ipsos’ global healthcare business, consolidates Ipsos’ extensive capabilities in capturing and analysing real-world data with our deep understanding of compliance and regulations to create robust real-world evidence, an area of increasing priority for healthcare companies.
As healthcare costs rise, and pressure to demonstrate the value of healthcare products intensifies, so does the need for robust real-world evidence. Ipsos’ dedicated Centre of Expertise (CoE) consolidates Ipsos’ global capabilities to better meet this growing demand.
Ipsos’ global RWE CoE designs bespoke studies to achieve our clients’ specific RWE objectives. Solutions are drawn from a comprehensive portfolio of evidence generation planning & consultancy, primary and secondary data studies, as well as publication and data visualisation of results. All studies are conducted in full compliance with GxP processes and relevant country regulations.
Ipsos’ global RWE solution is led by William Rogers, who joined Ipsos with extensive experience in running both commercial and medical functions in pharmaceutical and clinical research organisations (CROs). In these capacities, he has successfully managed teams who have set-up and delivered complex global RWE studies. These studies have led to various clinical and scientific outputs ranging from journal publications to supplementing regulatory submissions and supporting pricing and reimbursement (P&R) activities. Internally at Ipsos, William chairs the RWE CoE, which pulls together a multinational and multidisciplinary team of RWE experts.
Joern Kleebach, a member of Ipsos’ senior RWE leadership team, has more than 30 years of experience in healthcare insights and evidence functions. Joern leads the Global Commercial Development for Ipsos’ RWE studies. His comprehensive experience in designing and operationalising RWE for the Healthcare and MedTech sectors provides him with unique expertise that establishes him as an industry leader in the field of scientific evidence generation.
Ipsos prides itself in pioneering new innovative ways to generate real-world evidence for healthcare sector clients.
Not only have we been generating RWE for clinical use for several years, but we have focused on bringing innovative RWE solutions to our clients. Ipsos is the market leaders in Direct-to-Responder RWE studies, providing our clients with the unique ability to capture RWE directly from healthcare stakeholders including patients, carers, healthcare practitioners, payors, regulators and many more. This RWE approach provides our clients with the ability to rapidly generate meaningful and scientifically robust RWE. Ipsos provides traditional site-based RWE studies, as well as the ability to leverage our proprietary AI, Ipsos Facto, to search, validate and collect secondary RWE from a multitude of secondary data sources.
Real-world evidence (RWE) generation is crucial for articulating the value of our client’s healthcare solutions, scientific development, establishing regulatory standards, and making informed decisions. At Ipsos, we take immense pride in assisting our clients in the pharmaceutical and life sciences industries with their evidence-planning and generation needs for scientific or regulatory purposes. Our dedicated team of professionals works diligently to ensure that the evidence generated is robust, defensible, and instrumental in advancing healthcare solutions that improve patient outcomes.
Joern Kleebach
Global Commercial Development Director, RWE, Ipsos
Healthcare needs the ability to see, and more importantly, hear multiple stakeholders to make informed choices. Our Direct-to-Responder RWE studies provide our clients with the unique ability to collect RWE from a range of healthcare stakeholders around a core scientific question. Ipsos, and our clients, recognize that the patient is the most motivated stakeholder in healthcare, providing a powerful source of RWE. Ipsos champions patient-centricity, dedicated to ensuring the patient’s voice is amplified to provide meaningful RWE that positively impacts the healthcare landscape and future patients’ lives.
William Rogers, PhD, EMBA
Senior Vice President, RWE, Ipsos
As the costs of healthcare rise around the world, our clients are under increasing pressure to demonstrate the value, safety and efficacy of their drug, device or diagnostic – and to do so using robust clinical evidence. We are delighted to bring the best of Ipsos to meet their needs in this critical area.
Jo Appleton, PhD
Chief Commercial Officer, Global Healthcare, Ipsos
What is Real-World Evidence?
RWE follows rigorous clinical processes to transform data captured outside clinical trials (real-world data) into scientifically robust evidence, used by healthcare companies across the product lifecycle to demonstrate the value of their products to regulators, payors, prescribers and patients.
